A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus
收藏DataCite Commons2025-12-08 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000732/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether albiglutide is effective in the treament of patients with type 2 diabetes.
提供机构：
Vivli
创建时间：
2018-10-27
